Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models.
Saved in:
| Title: | Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models. |
|---|---|
| Authors: | Kuo, Chun-Ting1, Chen, Chen-Lin1, Li, Chih-Chi1, Huang, Guan-Syuan1, Ma, Wei-Yuan1, Hsu, Wei-Fan1, Lin, Ching-Hung2, Lu, Yen-Shen2 yslu@ntu.edu.tw, Wo, Andrew M.1 andrew@iam.ntu.edu.tw |
| Source: | Scientific Reports. 8/20/2020, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
